Drug profile · INN
lefamulin
XENLETA
lefamulin (XENLETA) is an FDA-listed pharmaceutical active ingredient.
EMA: approved Antiinfectives for systemic use (J01) J01XX
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — lefamulin
- Class
- Antiinfectives for systemic use (J01)
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.83
Quick answer
lefamulin (XENLETA) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN lefamulin
Brand XENLETA
Therapeutic class Antiinfectives for systemic use (J01)
ATC code J01XX
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is lefamulin?
lefamulin (XENLETA) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for lefamulin?
XENLETA is a marketed brand name for lefamulin. Check FDA Drugs@FDA for the current US label holder and prescribing information.